Sotera Health Co financials

  1. Home
  2. Financials
  3. SHC
SHC CIK 0001822479

Source: EDGAR filings · Built 2026-06-02T04:02:00Z

Custom taxonomy namespace: ffd

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Free Cash Flow 145.27M 37.01M -364.53M 94.52M 178.48M 65.58M
EBITDA — 381.93M 353.29M 312.65M 320.93M 269.32M
Working Capital 363.83M 335.04M 326.59M -146.56M 184.80M 174.42M
Net Debt 1.93B 2.07B 2.03B 1.64B 1.72B 1.81B
Gross Margin 55.48% 54.73% 55.00% 55.50% 55.68% 54.22%
Operating Margin — 27.05% 26.37% 24.74% 27.56% 25.18%
Net Margin 6.70% 4.03% 4.90% -23.27% 12.55% -4.72%
Return on Equity (ROE) 12.86% 10.96% 11.58% -66.69% 19.94% -8.54%
Return on Assets (ROA) 2.39% 1.45% 1.64% -7.49% 4.19% -1.40%
Current Ratio 2.46× 2.75× 2.42× 0.81× 2.15× 2.24×
Debt-to-Equity 3.75× 5.81× 5.24× 5.80× 3.12× 4.22×
Effective Tax Rate 47.16% 61.01% 51.54% 3.92% 33.35% 3.52%
Cash Conversion Ratio 3.68× 5.05× -2.88× -1.19× 2.41× -3.12×
Accruals Ratio -0.06× -0.06× 0.06× -0.16× -0.06× -0.06×
SBC % of Revenue 2.65% 3.34% 3.07% 2.11% 1.49% 1.34%
CapEx Coverage 2.02× 1.20× -0.68× 1.52× 2.73× 2.19×
Free Cash Flow Per Share $0.51 $0.13 $-1.29 $0.34 $0.64 $0.28

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
P/E Trailing (Diluted) 65.33× 85.50× 93.61× — 57.44× —
P/FCF 34.78× 105.31× — 24.69× 36.87× 99.46×
FCF Yield 2.88% 0.95% — 4.05% 2.71% 1.01%
EV / EBITDA — 15.67× 19.39× 12.86× 26.35× 35.85×
P/S 4.34× 3.56× 4.59× 2.37× 7.23× 9.59×
P/B 8.33× 9.66× 10.86× 6.80× 11.49× 17.35×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Revenue from Contract with Customer, Excluding Assessed Tax 1.16B 1.10B 1.05B 1.00B 931.48M 818.16M
Cost of Revenue 518.08M 498.15M 472.13M 446.68M 412.81M 374.59M
Gross Profit 645.53M 602.29M 577.16M 557.00M 518.67M 443.57M
Selling, General and Administrative Expense 252.76M 242.63M 236.67M 245.71M 198.16M 178.53M
Operating Expenses — 304.67M 300.47M 308.65M 261.94M 237.55M
Operating Income (Loss) — 297.63M 276.69M 248.35M 256.73M 206.02M
Income Tax Expense (Benefit) 69.56M 69.48M 54.65M -9.54M 58.59M -1.37M
Net Income (Loss) Attributable to Parent 77.95M 44.40M 51.38M -233.57M 116.88M -38.62M
Earnings Per Share, Basic $0.27 $0.16 $0.18 $-0.83 $0.41 $-0.16
Weighted Average Number of Shares Outstanding, Basic 283.96M 282.78M 281.01M 280.10M 279.23M 237.70M
Earnings Per Share, Diluted $0.27 $0.16 $0.18 $-0.83 $0.41 $-0.16
Weighted Average Number of Shares Outstanding, Diluted 286.42M 284.91M 283.22M 280.10M 279.38M 237.70M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Cash and Cash Equivalents, at Carrying Value 344.62M 277.24M 296.41M 395.21M 106.92M 102.45M
Assets, Current 613.41M 526.04M 557.24M 645.01M 345.96M 315.01M
Assets 3.26B 3.07B 3.13B 3.12B 2.79B 2.76B
Long-term Debt 2.14B 2.22B 2.23B 1.94B 1.74B 1.82B
Liabilities, Current 249.58M 191.00M 230.65M 791.57M 161.16M 140.60M
Long-term Debt, Excluding Current Maturities 2.13B 2.21B 2.22B 1.75B 1.74B 1.82B
Liabilities 2.66B 2.67B 2.69B 2.77B 2.20B 2.31B
Stockholders' Equity Attributable to Parent 606.03M 404.91M 443.73M 350.24M 586.10M 452.30M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Net Cash Provided by (Used in) Operating Activities 287.19M 224.16M -147.73M 277.96M 281.55M 120.58M
Payments to Acquire Property, Plant, and Equipment 138.02M 179.07M 214.97M 182.38M 102.16M 53.51M
Net Cash Provided by (Used in) Investing Activities -135.14M -179.00M -214.91M -181.90M -159.83M -158.69M
Payments for Repurchase of Common Stock — — — 0 0 34.00M
Payments of Dividends — — — — 0 0
Net Cash Provided by (Used in) Financing Activities -100.53M -50.56M 265.96M 197.76M -117.29M 73.43M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (SHC CIK 0001822479), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

TJX

The TJX Companies, Inc.

COLD

AMERICOLD REALTY TRUST, INC.

LZM

Lifezone Metals Limited